April 27, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline for certain cancer patients.

April 27, 2012

A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

April 26, 2012

Drug makers in the United States are developing nearly 300 vaccines for preventing and treating diseases, according to a new report by a drug industry trade group.

April 26, 2012

Patients with a rare, life-threatening genetic immune system disorder can receive treatment for sudden episodes more quickly and cost-effectively at home than if they go to the emergency room, according to a Walgreens Infusion Services study being presented Wednesday at the National Home Infusion Association Annual Conference and Exposition here.

April 25, 2012

Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.

April 25, 2012

GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.

April 24, 2012

Specialty pharmacy provider BioScrip has appointed Hai Tran as SVP, treasurer and CFO, the company said.

April 24, 2012

Globalization has led to a rapid increase in the drugs and foods arriving on U.S. shores from abroad, a trend that has prompted U.S. regulators to transform their approach.

April 23, 2012

Anglo-Swedish drug maker AstraZeneca will buy a San Diego-based biotech company for $1.26 billion, the two said Monday.

April 20, 2012

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

April 20, 2012

Merck is testing two means of treating patients with chronic hepatitis C for anemia, a common side effect of certain treatments for the viral infection, the drug maker said.

April 19, 2012

A trade organization representing generic drug manufacturers announced Thursday its latest solution to the problem of drug shortages.

April 17, 2012

A specialty pharmacy provider has launched an application that it said will reduce the administrative burden of reimbursement, writing prescriptions, monitoring adherence and reviewing drug lists.

April 17, 2012

Workers' compensation pharmacy costs took on an extra $2.1 billion in 2011 due to unnecessary use of more expensive drugs, according to a new report by pharmacy benefit manager Express Scripts.

April 16, 2012

Fresh off the heels of its merger with Medco Health Solutions, pharmacy benefit manager Express Scripts announced Monday the launch of a medication nonadherence detection system and offered a preview of its annual "Drug Trend Report."

April 16, 2012

The Food and Drug Administration is requesting additional data from two drug makers for a treatment for immune system disorders.

April 16, 2012

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

April 13, 2012

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

April 13, 2012

With the rise in people diagnosed with complex illnesses like cancers, multiple sclerosis, rheumatoid arthritis, hepatitis, Crohn’s disease and rare genetic disorders, the need for specialty pharmacies to deal with the complex drug regimens they require will rise as well.


April 13, 2012

One of the highlights for Rite Aid’s business has been Wellness+, its loyalty card program that has played a major role in driving growth in the company’s comps, as well as attracting new and more loyal customers.


April 13, 2012

Walmart and healthcare partner Humana are out with a new prescription drug program called Rx4Value that guarantees savings and relies on the proven strategy of improving affordability by restricting choice to generic drugs.

April 12, 2012

Diplomat Specialty Pharmacy has appointed a longtime specialty pharmacy executive to its executive team, the company said Thursday.

April 12, 2012

Valeant announced that it has acquired a privately owned specialty pharmaceutical company based in the United States.

April 11, 2012

A federal judge in Pittsburgh will rule "later" on whether to block or allow a merger between pharmacy benefit managers Medco Health Solutions and Express Scripts, and is considering a request by two trade groups seeking to keep Medco's operations and assets separate from ESI while the lawsuit is pending, according to published reports.